Clinical trials
Poliomyelitis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sinovac Biotech Co., Ltd | 13 |
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 7 |
| GlaxoSmithKline | 6 |
| Sanofi Pasteur, a Sanofi Company | 5 |
| Centers for Disease Control and Prevention, China | 4 |
| Chinese Academy of Medical Sciences | 3 |
| Jiangsu Province Centers for Disease Control and Prevention | 3 |
| Beijing Minhai Biotechnology Co., Ltd | 2 |
| Sanofi | 2 |
| Zhejiang Provincial Center for Disease Control and Prevention | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Poliomyelitis | 48 |
| Tetanus | 6 |
| Diphtheria | 5 |
| Haemophilus Infections | 4 |
| Whooping Cough | 4 |
| Hepatitis A | 2 |
| HIV Seropositivity | 1 |
| Measles | 1 |
| Mumps | 1 |
| Rubella | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.